Predicting lupus disease activity with blood tests
Part of Immune system & allergy clinical trials.
This study looks at whether two blood markers (AGR and PNI) can help track how active lupus is. You may be eligible if you have lupus and are not pregnant or have other serious health conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with systemic lupus erythematosus (SLE).
- You are not pregnant or breastfeeding.
- You do not have another autoimmune disease or chronic infection.
- You have not had a serious infection in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a simple blood test (called the Systemic Immune Inflammatory Index) to see if it can help doctors understand how active lupus is in your body. It includes people with lupus, especially those with kidney involvement, to find better ways to track the disease.
This study looks at whether two blood test markers (called T IgG and T IgM) can help doctors understand how active your lupus is and how much damage the disease has caused. If you join, your blood will be tested, and the results may help guide your treatment.
This study looks at a protein called CXCL5 in the blood of people with lupus and whether its level relates to how active the disease is. It is a simple blood test that might help doctors understand lupus activity better.
This study uses a simple blood test to estimate the risk of heart and blood vessel problems in people with lupus nephritis. It aims to find early signs of heart disease before symptoms appear.
This study aims to see if a blood test that measures a specific protein-related molecule can help doctors know how active your lupus is. If successful, this could lead to a simpler way to monitor the disease and adjust treatment.
This study looks at two blood tests (albumin/globulin ratio and platelet/albumin ratio) to see if they can help understand lupus nephritis, a serious kidney problem caused by lupus. If you have lupus nephritis, your participation may help improve how doctors monitor and manage this condition.
Hear when a new Systemic Lupus Erythematosus Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.